Your browser doesn't support javascript.
loading
Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium.
Li, Hongyan; Terry, Mary Beth; Antoniou, Antonis C; Phillips, Kelly-Anne; Kast, Karin; Mooij, Thea M; Engel, Christoph; Noguès, Catherine; Stoppa-Lyonnet, Dominique; Lasset, Christine; Berthet, Pascaline; Mari, Veronique; Caron, Olivier; Barrowdale, Daniel; Frost, Debra; Brewer, Carole; Evans, D Gareth; Izatt, Louise; Side, Lucy; Walker, Lisa; Tischkowitz, Marc; Rogers, Mark T; Porteous, Mary E; Snape, Katie; Meijers-Heijboer, Hanne E J; Gille, Johan J P; Blok, Marinus J; Hoogerbrugge, Nicoline; Daly, Mary B; Andrulis, Irene L; Buys, Saundra S; John, Esther M; McLachlan, Sue-Anne; Friedlander, Michael; Tan, Yen Y; Osorio, Ana; Caldes, Trinidad; Jakubowska, Anna; Simard, Jacques; Singer, Christian F; Olah, Edith; Navratilova, Marie; Foretova, Lenka; Gerdes, Anne-Marie; Roos-Blom, Marie-José; Arver, Brita; Olsson, Håkan; Schmutzler, Rita K; Hopper, John L; Milne, Roger L.
Affiliation
  • Li H; Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah.
  • Terry MB; Department of Epidemiology, Columbia University, New York, New York.
  • Antoniou AC; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.
  • Phillips KA; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, United Kingdom.
  • Kast K; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Victoria, Australia.
  • Mooij TM; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Engel C; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Noguès C; Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität, Dresden, Germany.
  • Stoppa-Lyonnet D; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany.
  • Lasset C; German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Berthet P; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Mari V; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany.
  • Caron O; Institut Paoli-Calmettes, Département d'Anticipation et de Suivi des Cancers, Oncogénétique Clinique and Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France.
  • Barrowdale D; Inserm, U830, Université Paris Descartes, Paris, France.
  • Frost D; Unité de prévention et Epidémiologie Génétique, Centre Léon Bérard - Lyon/UMR CNRS 5558, Université de Lyon - Lyon, France.
  • Brewer C; Département de biopathologie, Oncogénétique clinique, Centre François Baclesse - Caen, France.
  • Evans DG; CLCC Antoine Lacassagne, Département d'Hématologie - Oncologie médicale, Nice, France.
  • Izatt L; Département de Médecine, Gustave Roussy Hôpital Universitaire - Villejuif, France.
  • Walker L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, United Kingdom.
  • Tischkowitz M; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, United Kingdom.
  • Rogers MT; Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom.
  • Porteous ME; Genomic Medicine, NIHR Manchester Biomedical Research Centre, Manchester Academic Health Sciences Centre, Division of Evolution and Genomic Sciences, Manchester University, Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.
  • Snape K; Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Meijers-Heijboer HEJ; Oxford Regional Genetics Service, Churchill Hospital, Oxford, United Kingdom.
  • Gille JJP; University of Cambridge Department of Medical Genetics, NIHR Cambridge Biomedical Research Centre, and Cancer Research UK Cambridge Center, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Blok MJ; All Wales Medical Genetics Services, University Hospital of Wales, Cardiff, United Kingdom.
  • Hoogerbrugge N; South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom.
  • Andrulis IL; Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
  • Buys SS; Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
  • John EM; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands.
  • McLachlan SA; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Tan YY; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Osorio A; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Caldes T; Department of Medicine, University of Utah Health Sciences Center, Huntsman Cancer Institute, Salt Lake City, Utah.
  • Jakubowska A; Stanford University School of Medicine, Department of Medicine, Division of Oncology, and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.
  • Simard J; Department of Medicine, St. Vincent's Hospital, The University of Melbourne, Parkville, Victoria, Australia.
  • Singer CF; Department of Medical Oncology, St. Vincent's Hospital, Fitzroy, Victoria, Australia.
  • Olah E; Department of Medical Oncology, Prince of Wales Hospital, Randwick, New South Wales, Australia.
  • Navratilova M; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Gerdes AM; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Roos-Blom MJ; Human Genetics Group, Spanish National Cancer Centre (CNIO) and Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
  • Arver B; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, CIBERONC (ISCIII), Madrid, Spain.
  • Olsson H; Department of Genetics and Pathology, Pomeranian Medical University, Unii Lubelskiej 1, Szczecin, Poland.
  • Schmutzler RK; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.
  • Hopper JL; Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Quebec City, Quebec, Canada.
  • Milne RL; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Cancer Epidemiol Biomarkers Prev ; 29(2): 368-378, 2020 02.
Article de En | MEDLINE | ID: mdl-31792088
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Consommation d'alcool / Fumer des cigarettes / Mode de vie Type d'étude: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Middle aged Langue: En Journal: Cancer Epidemiol Biomarkers Prev Sujet du journal: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Année: 2020 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Consommation d'alcool / Fumer des cigarettes / Mode de vie Type d'étude: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Middle aged Langue: En Journal: Cancer Epidemiol Biomarkers Prev Sujet du journal: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Année: 2020 Type de document: Article